FDA Needs To Weigh Foreign Inspections More Heavily - SOCMA
This article was originally published in The Tan Sheet
Executive Summary
Despite plans to increase overseas inspections for fiscal 2010, FDA's refusal to risk-rank domestic and foreign manufacturers together puts U.S. firms at a disadvantage, according to the Society of Chemical Manufacturers and Affiliates
You may also be interested in...
FDA Foreign Inspections To Double In 2010, Led By Human Drugs And Food
FDA will shoot to double its inspections of foreign facilities in fiscal 2010 to more than 2,000
FDA Seeks Public Input On Secrets Of Profit-Motivated Adulteration
FDA plans to hold a public workshop this spring to begin the task of combating profit-motivated adulteration of regulated products
Import Contamination Risk Looms Larger For OTCs, Ex-Regulators Say
Over-the-counter drugs made with imported ingredients are at greater risk of contamination than prescription products, experts told a House panel on Nov. 1